Comerica Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-491
Closed -$2.57K 3839
2023
Q4
$2.57K Sell
491
-135
-22% -$706 ﹤0.01% 3467
2023
Q3
$9.87K Buy
+626
New +$9.87K ﹤0.01% 3209
2022
Q4
$208K Sell
6,345
-1,950
-24% -$63.9K ﹤0.01% 2054
2022
Q3
$257K Sell
8,295
-1,310
-14% -$40.6K ﹤0.01% 1997
2022
Q2
$418K Sell
9,605
-375
-4% -$16.3K ﹤0.01% 1901
2022
Q1
$502K Buy
9,980
+1,080
+12% +$54.3K ﹤0.01% 1867
2021
Q4
$414K Sell
8,900
-1,050
-11% -$48.8K ﹤0.01% 1930
2021
Q3
$520K Sell
9,950
-419
-4% -$21.9K ﹤0.01% 1932
2021
Q2
$504K Sell
10,369
-786
-7% -$38.2K ﹤0.01% 2022
2021
Q1
$491K Sell
11,155
-565
-5% -$24.9K ﹤0.01% 2032
2020
Q4
$559K Sell
11,720
-481
-4% -$22.9K ﹤0.01% 1971
2020
Q3
$571K Buy
12,201
+1,847
+18% +$86.4K ﹤0.01% 1857
2020
Q2
$516K Buy
10,354
+583
+6% +$29.1K ﹤0.01% 1850
2020
Q1
$502K Buy
9,771
+299
+3% +$15.4K ﹤0.01% 1730
2019
Q4
$520K Buy
9,472
+24
+0.3% +$1.32K ﹤0.01% 1876
2019
Q3
$589K Sell
9,448
-100
-1% -$6.23K ﹤0.01% 1809
2019
Q2
$520K Sell
9,548
-671
-7% -$36.5K ﹤0.01% 1862
2019
Q1
$488K Sell
10,219
-504
-5% -$24.1K ﹤0.01% 1897
2018
Q4
$444K Sell
10,723
-49
-0.5% -$2.03K ﹤0.01% 1908
2018
Q3
$627K Buy
10,772
+1,930
+22% +$112K 0.01% 1801
2018
Q2
$725K Buy
8,842
+130
+1% +$10.7K 0.01% 1797
2018
Q1
$481K Buy
8,712
+111
+1% +$6.13K ﹤0.01% 1920
2017
Q4
$514K Sell
8,601
-1,094
-11% -$65.4K ﹤0.01% 1910
2017
Q3
$504K Buy
9,695
+1,469
+18% +$76.4K ﹤0.01% 1896
2017
Q2
$599K Sell
8,226
-769
-9% -$56K ﹤0.01% 1779
2017
Q1
$814K Buy
8,995
+550
+7% +$49.8K 0.01% 1691
2016
Q4
$585K Buy
8,445
+415
+5% +$28.7K ﹤0.01% 1810
2016
Q3
$517K Buy
+8,030
New +$517K ﹤0.01% 1771